Group I | Group II | |
Patients, n (%) | 598 | 661 |
Female | 316 (53) | 337 (51) |
Male | 282 (47) | 322 (48) |
Other | 0 | 2 (1) |
Age in years, mean±SD (range) | 60±19 (3–99) | 59±19 (12–98) |
Total number of ERCPs, n | 842 | 885 |
Initial ERCP | ||
1 | 598 | 661 |
Follow-up (F/U) ERCPs | 244 | 224 |
2 | 177 | 151 |
3 | 47 | 53 |
4 | 13 | 13 |
5 | 4 | 6 |
6 | 2 | 1 |
7 | 1 | 0 |
Indication for initial ERCP, n (%) | 598 | 661 |
CBD stone | 375 (63) | 384 (58) |
Malignant biliary stricture | 83 (14) | 108 (16) |
Benign biliary stricture | 40 (8) | 50 (8) |
Bile leak | 27 (5) | 20 (3) |
Stent removal | 18 (3) | 18 (3) |
Chronic pancreatitis | 9 (2) | 21 (3) |
Balloon-assisted ERCP | 5 (1) | 17 (3) |
Sphincter of Oddi dysfunction | 7 (1) | 11 (2) |
Acute pancreatitis | 9 | 8 |
Occluded stent | 5 | 6 |
Ampullectomy | 7 | 4 |
Mirizzi’s syndrome | 0 | 4 |
Pancreatic leak | 5 | 4 |
Cholangioscopy | 1 | 2 |
Postsphincterotomy bleed | 1 | 2 |
Pancreatitis prophylaxis | 2 | 1 |
Unclear | 1 | 1 |
Abdominal pain | 1 | 0 |
Recurring pancreatitis | 2 | 0 |
Intervention during F/U ERCP, n (%) | 244 | 224 |
Stent removal | 126 (52) | 91 (41) |
Stent replacement | 61 (25) | 39 (17) |
Stent placement | 28 (11) | 48 (21) |
Stone extraction | 8 (3) | 11 (5) |
No intervention | 15 | 12 (5) |
Dilation | 1 | 9 |
Failed cannulation | 1 | 9 |
Sphincterotomy only | 4 | 3 |
Brushings/biopsy | 0 | 1 |
Rendezvous ERCP | 0 | 1 |
CBD, common bile duct; ERCP, endoscopic retrograde cholangiopancreatography.